Esomeprazole (esomeprazole): Reviews and patient testimonials

Esomeprazole 20 mg Gastro-resistant Capsules, Hard

Esomeprazole is indicated for:

Adults:

Gastro-oesophageal Reflux Disease (GORD)

- Treatment of erosive reflux oesophagitis

- Long-term management of patients with healed oesophagitis to prevent relapse

- Symptomatic treatment of gastro-esophageal reflux disease (GORD)

In combination with an appropriate antibacterial therapeutic regimen for the eradication of Helicobacter pylori and

- healing of Helicobacter pylori associated duodenal ulcer and

- prevention of relapse of peptic ulcers in patients with Helicobacter pylori associated ulcers.

Patients requiring continued NSAID therapy

Healing of gastric ulcers associated with NSAID therapy.

Prevention of gastric and duodenal ulcers associated with NSAID therapy, in patients at risk.

Prolonged treatment after i.v. induced prevention of rebleeding of peptic ulcers.

Treatment of Zollinger Ellison Syndrome

Adolescents from the age of 12 years

Gastro-oesophageal Reflux Disease (GORD)

- treatment of erosive reflux oesophagitis

- long-term management of patients with healed oesophagitis to prevent relapse

- symptomatic treatment of gastro-oesophageal reflux disease (GORD)

In combination with antibiotics in treatment of duodenal ulcer caused by Helicobacter pylori.

Esomeprazole 20 mg Gastro-resistant Tablets

Esomeprazole Gastro-resistant tablets are indicated in adults for:

Gastroesophageal Reflux Disease (GERD)

- treatment of erosive reflux esophagitis

- long-term management of patients with healed esophagitis to prevent relapse

- symptomatic treatment of gastroesophageal reflux disease (GERD)

In combination with appropriate antibacterial therapeutic regimens for the eradication of Helicobacter pylori and

- healing of Helicobacter pylori associated duodenal ulcer and

- prevention of relapse of peptic ulcers in patients with Helicobacter pylori associated ulcers

Patients requiring continued NSAID therapy

- healing of gastric ulcers associated with NSAID therapy.

- prevention of gastric and duodenal ulcers associated with NSAID therapy, in patients at risk.

Prolonged treatment after I.V. induced prevention of rebleeding of peptic ulcers

Treatment of Zollinger Ellison Syndrome

Esomeprazole Gastro-resistant tablets are indicated in adolescents from the age of 12 years for:

Gastroesophageal Reflux Disease (GERD)

- treatment of erosive reflux esophagitis

- long-term management of patients with healed esophagitis to prevent relapse

- symptomatic treatment of gastroesophageal reflux disease (GERD)

In combination with antibiotics in treatment of duodenal ulcer caused by Helicobacter pylori

Esomeprazole 20mg Gastro-resistant capsules, hard

Adults

Esomeprazole capsules are indicated in adults for:

Gastroesophageal Reflux Disease (GORD)

- treatment of erosive reflux esophagitis

- long-term management of patients with healed esophagitis to prevent relapse

- symptomatic treatment of gastroesophageal reflux disease (GORD)

In combination with appropriate antibacterial therapeutic regimens for the eradication of Helicobacter pylori and

- healing of Helicobacter pylori associated duodenal ulcer and

- prevention of relapse of peptic ulcers in patients with Helicobacter pylori associated ulcers

Patients requiring continued NSAID therapy

Healing of gastric ulcers associated with NSAID therapy.

Prevention of gastric and duodenal ulcers associated with NSAID therapy, in patients at risk.

Prolonged treatment after i.v. induced prevention of rebleeding of peptic ulcers

Treatment of Zollinger Ellison Syndrome

Adolescents from the age of 12 years

Gastro-oesophageal Reflux Disease (GORD)

- treatment of erosive reflux oesophagitis

- long-term management of patients with healed oesophagitis to prevent relapse

- symptomatic treatment of gastro-oesophageal reflux disease (GORD)

In combination with antibiotics in treatment of duodenal ulcer caused by Helicobacter pylori

Esomeprazole 20mg Gastro-resistant Tablets

Adults

Esomeprazole 20mg tablets are indicated in adults for:

Gastro-oesophageal Reflux Disease (GORD)

- treatment of erosive reflux oesophagitis

- long-term management of patients with healed oesophagitis to prevent relapse

- symptomatic treatment of gastro-oesophageal reflux disease (GORD)

In combination with appropriate antibacterial therapeutic regimens for the eradication of Helicobacter pylori and

- healing of Helicobacter pylori associated duodenal ulcer and

- prevention of relapse of peptic ulcers in patients with Helicobacter pylori associated ulcers

Patients requiring continued NSAID therapy

- healing of gastric ulcers associated with NSAID therapy.

- prevention of gastric and duodenal ulcers associated with NSAID therapy, in patients at risk.

Treatment of Zollinger Ellison Syndrome

Esomeprazole 20mg tablets are indicated in adolescents from the age of 12 years for:

Gastro-oesophageal Reflux Disease (GORD)

- treatment of erosive reflux oesophagitis

- long-term management of patients with healed oesophagitis to prevent relapse

- symptomatic treatment of gastro-oesophageal reflux disease (GORD)

In combination with antibiotics in treatment of duodenal ulcer caused by Helicobacter pylori

Esomeprazole 40 mg Gastro-resistant Capsules, Hard

Esomeprazole is indicated for:

Adults:

Gastro-oesophageal Reflux Disease (GORD)

- Treatment of erosive reflux oesophagitis

- Long-term management of patients with healed oesophagitis to prevent relapse

- Symptomatic treatment of gastro-esophageal reflux disease (GORD)

In combination with an appropriate antibacterial therapeutic regimen for the eradication of Helicobacter pylori and

- healing of Helicobacter pylori associated duodenal ulcer and

- prevention of relapse of peptic ulcers in patients with Helicobacter pylori associated ulcers.

Patients requiring continued NSAID therapy

Healing of gastric ulcers associated with NSAID therapy.

Prevention of gastric and duodenal ulcers associated with NSAID therapy, in patients at risk.

Prolonged treatment after i.v. induced prevention of rebleeding of peptic ulcers.

Treatment of Zollinger Ellison Syndrome

Adolescents from the age of 12 years

Gastro-oesophageal Reflux Disease (GORD)

- treatment of erosive reflux oesophagitis

- long-term management of patients with healed oesophagitis to prevent relapse

- symptomatic treatment of gastro-oesophageal reflux disease (GORD)

In combination with antibiotics in treatment of duodenal ulcer caused by Helicobacter pylori.

Esomeprazole 40 mg Gastro-resistant Tablets

Esomeprazole Gastro-resistant tablets are indicated in adults for:

Gastroesophageal Reflux Disease (GERD)

- treatment of erosive reflux esophagitis

- long-term management of patients with healed esophagitis to prevent relapse

- symptomatic treatment of gastroesophageal reflux disease (GERD)

In combination with appropriate antibacterial therapeutic regimens for the eradication of Helicobacter pylori and

- healing of Helicobacter pylori associated duodenal ulcer and

- prevention of relapse of peptic ulcers in patients with Helicobacter pylori associated ulcers

Patients requiring continued NSAID therapy

- healing of gastric ulcers associated with NSAID therapy.

- prevention of gastric and duodenal ulcers associated with NSAID therapy, in patients at risk.

Prolonged treatment after I.V. induced prevention of rebleeding of peptic ulcers

Treatment of Zollinger Ellison Syndrome

Esomeprazole Gastro-resistant tablets are indicated in adolescents from the age of 12 years for:

Gastroesophageal Reflux Disease (GERD)

- treatment of erosive reflux esophagitis

- long-term management of patients with healed esophagitis to prevent relapse

- symptomatic treatment of gastroesophageal reflux disease (GERD)

In combination with antibiotics in treatment of duodenal ulcer caused by Helicobacter pylori

Esomeprazole 40 mg Powder for Solution for Injection/Infusion

Esomeprazole Sodium Injection is indicated for:

Adults

• gastric antisecretory treatment when the oral route is not possible, such as:

- gastroesophageal reflux disease (GORD) in patients with esophagitis and/or severe symptoms of reflux.

- healing of gastric ulcers associated with NSAID therapy.

- prevention of gastric and duodenal ulcers associated with NSAID therapy, in patients at risk.

• prevention of rebleeding following therapeutic endoscopy for acute bleeding gastric or duodenal ulcers.

Children and adolescents aged 1-18 years

• gastric antisecretory treatment when the oral route is not possible, such as:

- gastroesophageal reflux disease (GORD) in patients with erosive reflux esophagitis and/or severe symptoms of reflux.

Esomeprazole 40 mg powder for solution for injection/infusion.

Esomeprazole 40 mg powder for solution for injection/infusion is indicated in adults for:

• gastric antisecretory treatment when the oral route is not possible, such as:

- gastroesophageal reflux disease (GERD) in patients with oesophagitis and/or severe symptoms of reflux

- healing of gastric ulcers associated with NSAID therapy

- prevention of gastric and duodenal ulcers associated with NSAID therapy, in patients at risk.

• prevention of rebleeding following therapeutic endoscopy for acute bleeding gastric or duodenal ulcers.

Esomeprazole SUN 40 mg powder for solution for injection/infusion is indicated in children and adolescents aged 1-18 years for:

• gastric antisecretory treatment when the oral route is not possible, such as:

− gastroesophageal reflux disease (GERD) in patients with erosive reflux esophagitis and/or severe symptoms of reflux.

Esomeprazole 40mg Gastro-resistant capsules, hard

Adults

Esomeprazole capsules are indicated in adults for:

Gastroesophageal Reflux Disease (GORD)

- treatment of erosive reflux esophagitis

- long-term management of patients with healed esophagitis to prevent relapse

- symptomatic treatment of gastroesophageal reflux disease (GORD)

In combination with appropriate antibacterial therapeutic regimens for the eradication of Helicobacter pylori and

- healing of Helicobacter pylori associated duodenal ulcer and

- prevention of relapse of peptic ulcers in patients with Helicobacter pylori associated ulcers

Patients requiring continued NSAID therapy

Healing of gastric ulcers associated with NSAID therapy.

Prevention of gastric and duodenal ulcers associated with NSAID therapy, in patients at risk.

Prolonged treatment after i.v. induced prevention of rebleeding of peptic ulcers

Treatment of Zollinger Ellison Syndrome

Esomeprazole 40mg Gastro-resistant Tablets

Esomeprazole 40mg tablets are indicated in adults for:

Gastro-oesophageal Reflux Disease (GORD)

- treatment of erosive reflux oesophagitis

Prolonged treatment after i.v. induced prevention of rebleeding of peptic ulcers.

Treatment of Zollinger Ellison Syndrome

Esomeprazole 40mg tablets are indicated in adolescents from the age of 12 years for:

Gastro-oesophageal Reflux Disease (GORD)

- treatment of erosive reflux oesophagitis

Esomeprazole 40mg powder for solution for injection vials (Azevedos)

Esomeprazole for injection or infusion is indicated for:

Adults

• gastric antisecretory treatment when the oral route is not possible, such as:

▪ gastro-oesophageal reflux disease (GORD) in patients with oesophagitis and/or severe symptoms of reflux ▪ healing of gastric ulcers associated with NSAID therapy ▪ prevention of gastric and duodenal ulcers associated with NSAID therapy, in patients at risk.

• prevention of rebleeding following therapeutic endoscopy for acute bleeding gastric or duodenal ulcers

Children and adolescents aged 1-18 years

• gastric antisecretory treatment when the oral route is not possible, such as:

▪ gastro-oesophageal reflux disease (GORD) in patients with erosive reflux oesophagitis and/or severe symptoms of reflux.

Esomeprazole 40mg powder for solution for injection vials (Ibigen)

Esomeprazole is indicated in adults for:

• Gastric antisecretory treatment when the oral route is not possible such as:

- gastroesophageal reflux disease (GORD) in patients with oesophagitis and/or severe symptoms of reflux.

- healing of gastric ulcers associated with NSAID therapy

- prevention of gastric and duodenal ulcers associated with NSAID therapy, in patients at risk.

• Prevention of rebleeding following therapeutic endoscopy for acute bleeding gastric or duodenal ulcers.

Route of administration: Injectable, Oral
Molecule: esomeprazole